Krell Robert W, Regenbogen Scott E, Wong Sandra L
Department of Surgery, University of Michigan, Ann Arbor, Michigan.
Cancer. 2015 Jun 1;121(11):1755-61. doi: 10.1002/cncr.29253. Epub 2015 Jan 29.
There are many treatment options for metastatic colorectal cancer (CRC). However, to the authors' knowledge, national treatment patterns for metastatic CRC, and the stability of hospital treatment patterns over time, have not been well described.
Data from the 2006 through 2011 National Cancer Data Base were used to study adults with newly diagnosed metastatic CRC (84,161 patients from 1051 hospitals). Using hierarchical models, the authors characterized hospital volume in the use of different treatment modalities (primary site resection, metastatic site resection, chemotherapy, and palliative care). The authors then assessed variation in the receipt of treatment according to the hospitals' relative volume of services used. Finally, the extent to which hospital treatment patterns changed over the past decade was examined.
Overall use of volume of services varied widely (5.0% in the hospitals with low volumes of service to 22.3% in the hospitals with high volumes of service). As hospitals' volumes of services increased, adjusted rates of metastatic site surgery (6.6% to 30.8%; P<.001) and multiagent chemotherapy (37.8% to 57.4%; P<.001) use increased, but primary site resection demonstrated little variation (56.8% vs 59.5%; P = .024). It is interesting to note that use of palliative care also increased (8.1% to 11.3%; P = .002). Hospital treatment patterns did not change over time, with hospitals with high volumes of service consistently using more metastatic site resection and multiagent chemotherapy than hospitals with low volumes of service.
There is wide variation in hospital treatment patterns for patients with metastatic CRC, and these patterns have been stable over time. It appears that much of the approach for metastatic CRC treatment depends on the hospital in which the patient presents.
转移性结直肠癌(CRC)有多种治疗选择。然而,据作者所知,转移性CRC的全国治疗模式以及医院治疗模式随时间的稳定性尚未得到充分描述。
使用2006年至2011年国家癌症数据库的数据,研究新诊断为转移性CRC的成年人(来自1051家医院的84161名患者)。作者采用分层模型,描述了不同治疗方式(原发部位切除、转移部位切除、化疗和姑息治疗)的医院使用量。然后,作者根据医院使用的相对服务量评估了治疗接受情况的差异。最后,研究了过去十年中医院治疗模式的变化程度。
服务量的总体使用差异很大(服务量低的医院为5.0%,服务量高的医院为22.3%)。随着医院服务量的增加,转移部位手术(6.6%至30.8%;P<0.001)和多药化疗(37.8%至57.4%;P<0.001)的调整使用率增加,但原发部位切除变化不大(56.8%对59.5%;P = 0.024)。值得注意的是,姑息治疗的使用也有所增加(8.1%至11.3%;P = 0.002)。医院治疗模式没有随时间变化,服务量高的医院始终比服务量低的医院更多地使用转移部位切除和多药化疗。
转移性CRC患者的医院治疗模式存在很大差异,并且这些模式随时间一直保持稳定。转移性CRC的治疗方法似乎很大程度上取决于患者就诊的医院。